Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of HEXIM1 as a positive regulator of p53.
Lew QJ, Chia YL, Chu KL, Lam YT, Gurumurthy M, Xu S, Lam KP, Cheong N, Chao SH. Lew QJ, et al. Among authors: chia yl. J Biol Chem. 2012 Oct 19;287(43):36443-54. doi: 10.1074/jbc.M112.374157. Epub 2012 Sep 4. J Biol Chem. 2012. PMID: 22948151 Free PMC article.
HEXIM1, a New Player in the p53 Pathway.
Lew QJ, Chu KL, Chia YL, Cheong N, Chao SH. Lew QJ, et al. Among authors: chia yl. Cancers (Basel). 2013 Jul 4;5(3):838-56. doi: 10.3390/cancers5030838. Cancers (Basel). 2013. PMID: 24202322 Free PMC article.
Exposure-Response and Subgroup Analyses to Support Body Weight-Based Dosing of Brentuximab Vedotin in Children and Young Adults with Newly Diagnosed High-Risk Classical Hodgkin Lymphoma.
Zhang Z, Zhang D, Guo W, Fenton K, Narayanan S, Jain S, Jiang J, Castellino SM, Kelly KM, Cole PD, Keller FG, Garg A, Chia YL. Zhang Z, et al. Among authors: chia yl. Clin Cancer Res. 2024 May 29. doi: 10.1158/1078-0432.CCR-23-3655. Online ahead of print. Clin Cancer Res. 2024. PMID: 38810021
Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants.
Cheung TT, Mai TH, Chia YL, Yap DYH, Lee CH, Chen CC, Huang Y, Jin Y, Johnston J, Werkström V, Yao Y, Ge X, Zheng W. Cheung TT, et al. Among authors: chia yl. Drug Des Devel Ther. 2023 Jan 26;17:209-218. doi: 10.2147/DDDT.S392155. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 36726737 Free PMC article. Clinical Trial.
Population pharmacokinetic modelling of tremelimumab in patients with advanced solid tumours and the impact of disease status on time-varying clearance.
Hwang M, Chia YL, Zheng Y, Chen CC, He J, Song X, Zhou D, Goldberg SB, Siu LL, Planchard D, Peters S, Mann H, Krug L, Even C. Hwang M, et al. Among authors: chia yl. Br J Clin Pharmacol. 2023 May;89(5):1601-1616. doi: 10.1111/bcp.15622. Epub 2022 Dec 25. Br J Clin Pharmacol. 2023. PMID: 36454221 Free article.
24 results